Literature DB >> 19468191

Cytomegalovirus-associated protein-losing enteropathy resulting from lymphangiectasia in an immunocompetent child.

Takayuki Hoshina1, Koichi Kusuhara, Mitsumasa Saito, Takuya Hara, Shuji Mtsuura, Takashi Yano, Tomonobu Aoki, Toshiro Hara.   

Abstract

An immunocompetent 8-year-old boy with cytomegalovirus (CMV)-associated transient protein-losing enteropathy (PLE) is described. Colonoscopic examination revealed lymphoid hyperplasia of the terminal ileum. Histological examination of the biopsied specimens showed marked dilation of the lymphatic vessels. Primary CMV infection was demonstrated by serological test and polymerase chain reaction. The child had complete resolution of the disease without antiviral treatment. The present case suggests the etiologic role of CMV infection in PLE resulting from intestinal lymphangiectasia in childhood.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19468191

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  3 in total

1.  A Clinical Approach to a Child with Hypoalbuminemia and Lymphopenia.

Authors:  Ayse Sevgi Köstel-Bal; Suna Kaymak; Şule Haskoloğlu; Zarife Kuloğlu; Arzu Ensari; Figen Doğu; Aydan Kansu; Aydan İkincioğulları
Journal:  J Clin Immunol       Date:  2016-03-30       Impact factor: 8.317

2.  Primary intestinal lymphangiectasia: is it always bad? Two cases with different outcome.

Authors:  Ioannis Xinias; Antigoni Mavroudi; Evi Sapountzi; Agathi Thomaidou; Maria Fotoulaki; Athanasios Kalambakas; Elina Karypidou; Konstantinos Kollios; Grigorios Pardalos; George Imvrios
Journal:  Case Rep Gastroenterol       Date:  2013-03-20

3.  Intestinal lymphangiectasia in a 3-month-old girl: A case report of Hennekam syndrome caused by CCBE1 mutation.

Authors:  Antonella Fattorusso; Elena Sofia Pieri; Giovanni Battista Dell'Isola; Paolo Prontera; Elisabetta Mencaroni; Gabriela Stangoni; Susanna Esposito
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.